Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders (Q36691446)

15 August 2017

1 reference

title

Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders (English)

1 reference

15 August 2017

Todd PA

1

1 reference

15 August 2017

Fitton A

series ordinal

2

1 reference

15 August 2017

publication date

1 July 1991

1 reference

15 August 2017

number of pages

25

1 reference

inferred from page(s)

published in

Drugs

1 reference

15 August 2017

volume

42

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

90-114

1 reference

Hypertrophy induced alteration of action potential and effects of the inhibition of angiotensin converting enzyme by perindopril in infarcted rat hearts

15 August 2017

cites work

1 reference

12 December 2020

Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension

1 reference

12 December 2020

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects

1 reference

12 December 2020

Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor

1 reference

12 December 2020

Vascular effects of ACE inhibition by perindopril

1 reference

12 December 2020

Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer.

1 reference

12 December 2020

Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors: measurement of relative inhibitory potency and serum drug levels by radioinhibitor binding displacement assay

1 reference

12 December 2020

Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, restores the lower limit of autoregulation of cerebral blood flow in the awake renovascular hypertensive rat.

1 reference

12 December 2020

The safety and tolerability of lisinopril in clinical trials

1 reference

12 December 2020

Effects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography

1 reference

12 December 2020

Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension

1 reference

12 December 2020

Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

Beneficial effect of perindopril, an angiotensin-converting enzyme inhibitor, on left ventricular performance and noradrenaline myocardial content during cardiac failure development in the rat

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis

1 reference

12 December 2020

Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure

1 reference

12 December 2020

Antihypertensive effect of perindopril: experimental pharmacology

1 reference

12 December 2020

Myocardial and vascular effects of perindopril, a new converting enzyme inhibitor, during hypertension development in spontaneously hypertensive rats

1 reference

12 December 2020

Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors

1 reference

12 December 2020

Effect of prolonged angiotensin converting enzyme inhibition on ambulatory blood pressure of normotensive volunteers

1 reference

12 December 2020

Effect of antihypertensive treatment on the left ventricular isomyosin profile in one-clip, two kidney hypertensive rats

1 reference

12 December 2020

Pharmacokinetics of perindopril and its metabolites in healthy volunteers

1 reference

12 December 2020

Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders

1 reference

12 December 2020

[First intention treatment of arterial hypertension. Effectiveness and safety of perindopril]

1 reference

12 December 2020

Perindopril, a new angiotensin converting enzyme inhibitor--clinical pharmacological studies in healthy subjects

1 reference

12 December 2020

Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors

1 reference

12 December 2020

Radioimmunoassay of a new angiotensin-converting enzyme inhibitor (perindopril) in human plasma and urine: advantages of coupling anion-exchange column chromatography with radioimmunoassay

1 reference

12 December 2020

Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril

1 reference

12 December 2020

Differential angiotensin-converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography

1 reference

12 December 2020

Antirenin immunization versus angiotensin converting enzyme inhibition in rats

1 reference

12 December 2020

Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Antihypertensive effects of S9490-3, a new converting enzyme inhibitor, in the conscious spontaneously hypertensive rat

1 reference

12 December 2020

Captopril versus perindopril: a double blind study in essential hypertension

1 reference

12 December 2020

PRESSOR SENSITIVITY TO ANGIOTENSIN I AND ANGIOTENSIN II DURING THE DEVELOPMENT OF EXPERIMENTAL RENAL HYPERTENSION IN THE RAT

1 reference

12 December 2020

Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.

1 reference

12 December 2020

Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group

1 reference

12 December 2020

Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats

1 reference

12 December 2020

Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril

1 reference

12 December 2020

A double blind comparison of perindopril and atenolol in essential hypertension

1 reference

12 December 2020

Evaluation of the dose-effect relationship of a new ace inhibitor (perindopril) by an automatic blood pressure recorder

1 reference

12 December 2020

Adverse reactions with angiotensin converting enzyme (ACE) inhibitors

1 reference

12 December 2020

Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats

1 reference

12 December 2020

Effects of chronic converting enzyme inhibition on the structure and function of large arteries in the rat.

1 reference

12 December 2020

The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients

1 reference

12 December 2020

Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring

1 reference

12 December 2020

The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects

1 reference

12 December 2020

Angiotensin converting enzyme in the rat heart: studies of its inhibition in vitro and ex vivo

1 reference

12 December 2020

Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril

1 reference

12 December 2020

Systemic and regional hemodynamic interactions of perindopril and nitrendipine in the spontaneously hypertensive rat

1 reference

12 December 2020

Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects

1 reference

12 December 2020

Comparison of the actions of the angiotensin-converting enzyme inhibitors enalapril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats

1 reference

12 December 2020

Biotransformation studies of di-acid angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study

1 reference

12 December 2020

Perindopril. A review of its pharmacokinetics and clinical pharmacology

1 reference

12 December 2020

Influence of age on the pharmacokinetics and pharmacodynamics of perindopril

1 reference

12 December 2020

Experience with perindopril in normal volunteers

1 reference

12 December 2020

Effect of perindopril on the renal haemodynamic changes associated with adaptation to sodium restriction in the rat.

1 reference

12 December 2020

Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.

1 reference

12 December 2020

Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study

1 reference

12 December 2020

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Tolerance and safety of perindopril

1 reference

12 December 2020

High affinity binding sites for Perindopril a new inhibitor of angiotensin-I-converting enzyme (ACE) in the rabbit kidney: possible evidence for localization of ACE in endothelial structures and in glomerular mesangium

1 reference

12 December 2020

Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension.

1 reference

12 December 2020

The effect of perindopril on blood pressure in humans on different sodium intakes

1 reference

12 December 2020

Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels during perindopril therapy of chronic left ventricular failure in rats

1 reference

12 December 2020

Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension

1 reference

12 December 2020

Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.

1 reference

12 December 2020

Relative inhibitory potency and plasma drug levels of angiotensin converting enzyme inhibitors in the rat

1 reference

12 December 2020

Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term

1 reference

12 December 2020

Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency

1 reference

12 December 2020

[Ambulatory registration of arterial pressure during treatment with perindopril. Effects on systolic pressure and hemodynamic implications]

1 reference

12 December 2020

Perindopril, a new converting enzyme inhibitor: systemic and regional hemodynamics and sympathoinhibitory effects in spontaneously hypertensive rats

1 reference

12 December 2020

Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction

1 reference

12 December 2020

Renal function, glycaemic control and perindopril in diabetic patients

1 reference

12 December 2020

What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.

1 reference

12 December 2020

Systemic and regional hemodynamic effects of perindopril in congestive heart failure

1 reference

12 December 2020

Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat.

1 reference

12 December 2020

Enhanced Brachial Artery Compliance Following Perindopril in Essential Hypertension

1 reference

12 December 2020

Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes

1 reference

12 December 2020

A double-blind comparison of perindopril and hydrochlorothiazide-amiloride in mild to moderate essential hypertension

1 reference

12 December 2020

Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension

1 reference

12 December 2020

Protective effect of angiotensin converting enzyme inhibitors (CEI): captopril and perindopril on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion in rat

1 reference

12 December 2020

[The effects of inhibition of converting enzyme by perindopril on renal hemodynamics and natriuresis in essential arterial hypertension]

1 reference

12 December 2020

10.2165/00003495-199142010-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1048302421

0 references

1 reference